Schott is planning to make further investments in its pharmaceutical packaging plant in Itupeva, Brazil, to cater to the increasing demand for pharma packaging.
During the last fiscal year, the company invested approximately R$15m ($4.95m) in its Itupeva facility, which produces quality ampoules, vials, and cartridges.
Go deeper with GlobalData
The products manufactured at the facility are used by pharmaceutical companies to store and administer life-saving medications to patients.
Commenting on the investment plans, Schott Pharmaceutical Systems business unit executive vice-president Andreas Reisse said: "Brazil in particular is a very interesting market for us.
"With these investments, we want to make sure that our South American customers are supplied in the best possible way."
The Itupeva facility meets international standards of quality (ISO 9000), environment (ISO 14000), occupational health and safety management (OHSAS 18000) and pharmaceutical production (GMP – Good Manufacturing Practice ISO 15378).
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataThis plant employs 500 people and operates production lines 24h a day, 365 days a year to contribute significantly to the nine billion units produced by the company worldwide per annum.
Schott Brazil Pharmaceutical Systems director Jürgen Buhr said: "The pharmaceutical industry in Brazil can make significant progress based on this growth in healthcare expenditure.
"And Schott will be a very supportive partner when it comes to realizing these growth objectives by supplying its customers with the highest quality pharmaceutical packaging."
According to IMS Health’s survey, Brazil is expected to secure fifth position among the major pharmaceutical markets in the world in 2018, displacing Germany in the process.
Image: Schott committed to further investments in Brazilian pharmaceutical packaging plant. Photo: courtesy of Schott.
